Neuronetics, Inc.
STIMNasdaqCIK 1227636HealthcareFiscal year ends Dec 31
Reports and events: 193 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2420:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-002299 |
| 2026-08-1716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-354051 |
| 2026-08-1116:26 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094078 |
| 2026-08-1108:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-343474 |
| 2026-08-0408:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193805-26-001017 |
| 2026-07-2016:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-308921 |
| 2026-06-2316:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-279601 |
| 2026-05-2916:45 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-248525 |
| 2026-05-2710:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-001483 |
| 2026-05-2207:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-235481 |
| 2026-05-0509:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-055322 |
| 2026-05-0508:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-205117 |
| 2026-04-0916:02 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001140361-26-013997 |
| 2026-04-0809:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-000945 |
| 2026-04-0616:40 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-143876 |
| 2026-03-3116:05 ET | SCHEDULE 13D | Ownership report, active investor | 0000921895-26-000850 |
| 2026-03-1708:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-029004 |
| 2026-03-1707:55 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-109403 |
| 2026-03-0417:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-091919 |
| 2026-03-0216:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-085509 |
| 2026-02-2516:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-071892 |
| 2026-02-1017:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-044912 |
| 2026-01-2207:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-018674 |
| 2026-01-0617:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-004728 |
| 2025-11-0407:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-105924 |
| 2025-11-0407:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-263541 |
| 2025-08-1216:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-107330 |
| 2025-08-0507:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010180 |
| 2025-08-0507:10 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-173033 |
| 2025-07-1507:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-159026 |
| 2025-05-2807:11 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-128678 |
| 2025-05-0607:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006384 |
| 2025-05-0607:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-113283 |
| 2025-04-1016:32 ET | DEF 14A | Proxy statementPeriod 2025-05-22 | 0001140361-25-013279 |
| 2025-03-2716:36 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003833 |
| 2025-03-2716:35 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-003832 |
| 2025-03-0407:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-044817 |
| 2025-03-0419:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-044451 |
| 2025-02-1018:12 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-022833 |
| 2025-02-0616:21 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-25-021800 |
| 2025-01-1308:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005006 |
| 2024-12-1721:15 ET | SC 13D | Ownership report, active investor | 0001193125-24-280667 |
| 2024-12-1016:45 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-274383 |
| 2024-11-1306:44 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-256576 |
| 2024-11-1320:25 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-256238 |
| 2024-11-1207:31 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015160 |
| 2024-11-1207:03 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-255114 |
| 2024-11-1207:01 ET | 8-K | 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001193125-24-255111 |
| 2024-11-1207:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255110 |
| 2024-11-0117:18 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-249941 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.